JP2017501848A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017501848A5 JP2017501848A5 JP2016553757A JP2016553757A JP2017501848A5 JP 2017501848 A5 JP2017501848 A5 JP 2017501848A5 JP 2016553757 A JP2016553757 A JP 2016553757A JP 2016553757 A JP2016553757 A JP 2016553757A JP 2017501848 A5 JP2017501848 A5 JP 2017501848A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- antibody
- humanized
- synuclein
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361906372P | 2013-11-19 | 2013-11-19 | |
| US61/906,372 | 2013-11-19 | ||
| PCT/IB2014/066141 WO2015075635A2 (en) | 2013-11-19 | 2014-11-19 | Monitoring immunotherapy of lewy body disease from constipation symptoms |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019171039A Division JP2020011978A (ja) | 2013-11-19 | 2019-09-20 | 便秘症状からのレビー小体病の免疫療法のモニター |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017501848A JP2017501848A (ja) | 2017-01-19 |
| JP2017501848A5 true JP2017501848A5 (https=) | 2017-12-28 |
Family
ID=52000905
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016553757A Pending JP2017501848A (ja) | 2013-11-19 | 2014-11-19 | 便秘症状からのレビー小体病の免疫療法のモニター |
| JP2019171039A Pending JP2020011978A (ja) | 2013-11-19 | 2019-09-20 | 便秘症状からのレビー小体病の免疫療法のモニター |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019171039A Pending JP2020011978A (ja) | 2013-11-19 | 2019-09-20 | 便秘症状からのレビー小体病の免疫療法のモニター |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US11191832B2 (https=) |
| EP (1) | EP3071974A2 (https=) |
| JP (2) | JP2017501848A (https=) |
| WO (1) | WO2015075635A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017501848A (ja) | 2013-11-19 | 2017-01-19 | プロセナ バイオサイエンシーズ リミテッド | 便秘症状からのレビー小体病の免疫療法のモニター |
| WO2015121339A1 (en) | 2014-02-14 | 2015-08-20 | RUHR-UNIVERSITäT BOCHUM | Biosensor for conformation and secondary structure analysis |
| ES2834484T3 (es) | 2016-11-21 | 2021-06-17 | Univ Ruhr Bochum | Método para la preselección de fármacos para enfermedades de plegamiento incorrecto de proteínas |
| BR112019013953A2 (pt) | 2017-01-06 | 2020-02-11 | Abl Bio Inc. | Anticorpo anti-a-syn e uso do mesmo |
| CA3051839A1 (en) | 2017-02-17 | 2018-08-23 | Bristol-Myers Squibb Company | Antibodies to alpha-synuclein and uses thereof |
| JP7075648B2 (ja) * | 2017-07-05 | 2022-05-26 | ディメンシア・フロント株式会社 | 脳機能疾病鑑別方法及び該方法を含むプログラムを実行するコンピュータプログラムプロダクト |
| WO2019064053A1 (en) * | 2017-09-28 | 2019-04-04 | Prothena Biosciences Limited | DOSAGE REGIMES FOR THE TREATMENT OF SYNUCLEINOPATHIES |
| US20190153102A1 (en) | 2017-09-28 | 2019-05-23 | Prothena Biosciences Limited | Dosing regimes for treatment of synucleinopathies |
| CA3081199A1 (en) * | 2017-11-14 | 2019-05-23 | Osaka University | Cognitive impairment diagnostic apparatus and cognitive impairment diagnostic program |
| EP3725806A4 (en) * | 2017-12-14 | 2022-03-30 | ABL Bio Inc. | BISPECIFIC ANTIBODIES AGAINST A-SYN/IGF1R AND ASSOCIATED USE |
| GB201720970D0 (en) | 2017-12-15 | 2018-01-31 | Ucb Biopharma Sprl | Antibodies |
| GB201720975D0 (en) | 2017-12-15 | 2018-01-31 | Ucb Biopharma Sprl | Anti-alpha synuclein antibodies |
| EP4268842A3 (en) * | 2019-06-14 | 2024-05-22 | ABL Bio, Inc. | BISPECIFIC ANTIBODY AGAINST a-SYN/IGF1R AND USE THEREOF |
| US20230265204A1 (en) * | 2020-04-24 | 2023-08-24 | Hoffmann-La Roche Inc. | Enzyme and pathway modulation with sulfhydryl compounds and their derivatives |
| TW202227131A (zh) | 2020-09-10 | 2022-07-16 | 愛爾蘭商普羅佘納生物科技有限公司 | 帕金森氏症之治療 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3521994A1 (de) | 1985-06-20 | 1987-01-02 | Bayer Ag | N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・２・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| CA2017507C (en) | 1989-05-25 | 1996-11-12 | Gary Van Nest | Adjuvant formulation comprising a submicron oil droplet emulsion |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| DE69435171D1 (de) | 1993-09-14 | 2009-01-08 | Pharmexa Inc | Pan dr-bindeproteinen zur erhöhung der immunantwort |
| US5786464C1 (en) | 1994-09-19 | 2012-04-24 | Gen Hospital Corp | Overexpression of mammalian and viral proteins |
| DE19539493A1 (de) | 1995-10-24 | 1997-04-30 | Thomae Gmbh Dr K | Starker homologer Promotor aus Hamster |
| AU705688B2 (en) | 1995-11-10 | 1999-05-27 | Cytogen Corporation | Peptides which enhance transport across tissues and methods of identifying and using the same |
| US5834597A (en) | 1996-05-20 | 1998-11-10 | Protein Design Labs, Inc. | Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same |
| US6114148C1 (en) | 1996-09-20 | 2012-05-01 | Gen Hospital Corp | High level expression of proteins |
| AUPO390396A0 (en) | 1996-11-29 | 1996-12-19 | Csl Limited | Novel promiscuous T helper cell epitopes |
| DK1005368T3 (da) | 1997-03-10 | 2010-01-04 | Ottawa Hospital Res Inst | Anvendelse af nukleinsyrer, der indeholder ikke-metyleret CpG dinukleotid i kombination med alun som hjælpestoffer |
| US5888809A (en) | 1997-05-01 | 1999-03-30 | Icos Corporation | Hamster EF-1α transcriptional regulatory DNA |
| NZ513144A (en) | 1999-02-05 | 2003-05-30 | Samsung Electronics Co Ltd | Image texture retrieving method and apparatus thereof |
| MXPA05000511A (es) | 2001-07-12 | 2005-09-30 | Jefferson Foote | Anticuepros super humanizados. |
| US8506959B2 (en) * | 2002-11-01 | 2013-08-13 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
| JP4344325B2 (ja) | 2002-11-29 | 2009-10-14 | ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | 新規なネオマイシンホスホトランスフェラーゼ遺伝子及び高生産組換え細胞の選抜方法 |
| PL2361928T3 (pl) | 2003-05-19 | 2017-09-29 | Prothena Biosciences Limited | Skrócone fragmenty alfa-synukleiny w chorobie z ciałami Lewy'ego |
| US7358331B2 (en) | 2003-05-19 | 2008-04-15 | Elan Pharmaceuticals, Inc. | Truncated fragments of alpha-synuclein in Lewy body disease |
| WO2005011389A1 (en) * | 2003-07-29 | 2005-02-10 | Fra Production S.P.A. | Machine for automatically presenting poultry to an operator entrusted with their tying |
| DE10338531A1 (de) | 2003-08-19 | 2005-04-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Reklonierung von Produktionszellen |
| WO2005047860A2 (en) * | 2003-11-08 | 2005-05-26 | Elan Pharmaceuticals, Inc. | Antibodies to alpha-synuclein |
| CA2578400C (en) | 2004-11-10 | 2014-01-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of flow-cytometric analysis to optimize cell banking strategies for cho cells |
| US8502016B1 (en) | 2005-02-11 | 2013-08-06 | Elan Pharmaceuticals, Inc. | Genomic alpha synuclein transgenic animal |
| US20080124760A1 (en) | 2006-07-26 | 2008-05-29 | Barbara Enenkel | Regulatory Nucleic Acid Elements |
| US20120142902A1 (en) | 2007-02-23 | 2012-06-07 | The Regents Of The University Of California | Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease |
| PL2583978T3 (pl) | 2007-02-23 | 2016-07-29 | Prothena Biosciences Ltd Co | Profilaktyka i leczenie chorób synukleinopatycznych i amyloidogennych |
| NZ580043A (en) | 2007-03-02 | 2012-04-27 | Boehringer Ingelheim Pharma | Improvement of protein production through increased expression of mutated start domain protein cert |
| EP2031064A1 (de) | 2007-08-29 | 2009-03-04 | Boehringer Ingelheim Pharma GmbH & Co. KG | Verfahren zur Steigerung von Proteintitern |
| RS63930B1 (sr) * | 2011-10-28 | 2023-02-28 | Prothena Biosciences Ltd | Humanizovana antitela koja prepoznaju alfa-sinuklein |
| JP2017501848A (ja) | 2013-11-19 | 2017-01-19 | プロセナ バイオサイエンシーズ リミテッド | 便秘症状からのレビー小体病の免疫療法のモニター |
-
2014
- 2014-11-19 JP JP2016553757A patent/JP2017501848A/ja active Pending
- 2014-11-19 US US15/037,978 patent/US11191832B2/en not_active Expired - Fee Related
- 2014-11-19 EP EP14805676.5A patent/EP3071974A2/en not_active Ceased
- 2014-11-19 WO PCT/IB2014/066141 patent/WO2015075635A2/en not_active Ceased
-
2019
- 2019-09-20 JP JP2019171039A patent/JP2020011978A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017501848A5 (https=) | ||
| JP2015505564A5 (https=) | ||
| JP2017079785A5 (https=) | ||
| JP2017149726A5 (https=) | ||
| JP2015525798A5 (https=) | ||
| JP2016530280A5 (https=) | ||
| JP2014533279A5 (https=) | ||
| EA201691454A1 (ru) | Композиции придопидина модифицированного высвобождения | |
| JP2015007098A5 (https=) | ||
| JP2016538270A5 (https=) | ||
| CO2017001875A2 (es) | Terapia de combinación contra el alzheimer usando anticuerpos anti-n3pglu más un inhibidor bace | |
| PH12015501531B1 (en) | Crenolanib for treating flt3 mutated proliferative disorders | |
| JP2016512817A5 (https=) | ||
| JP2016515628A5 (https=) | ||
| JP2016539125A5 (https=) | ||
| JP2012102122A5 (https=) | ||
| EA201790475A1 (ru) | Способы лечения системной красной волчанки с использованием доменного антитела против cd28 | |
| JP2019532047A5 (https=) | ||
| JP2017533220A5 (https=) | ||
| EA201791227A1 (ru) | РЕЖИМ ДОЗИРОВАНИЯ АНТАГОНИСТОВ MAdCAM | |
| JP2016510343A5 (https=) | ||
| MX2025001920A (es) | Tratamiento de enfermedades y trastornos asociados a las mitocondrias, incluyendo los sintomas de los mismos usando pridopidina | |
| MX2021004120A (es) | Regimen de dosificacion para antagonistas de tfpi. | |
| JP2018529661A5 (https=) | ||
| JP2016539122A5 (https=) |